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Identification and Characterization
of a Novel OCA-B Isoform: Implications
for a Role in B Cell Signaling Pathways
et al., 1990; Luo et al., 1992) and genetic (Corcoran et
al., 1993) analyses clearly demonstrated that this was
not the case. Instead, the promoter specificity was
shown to be due to an Oct-1 interacting factor called
OCA-B (Luo et al., 1992), and the purification of related
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p35 and p34 isoforms with apparently equivalent activity1230 York Avenue
in vitro (Luo and Roeder, 1995) set the stage for furtherNew York, New York 10021
studies of the structure and function of OCA-B.
Subsequent to the biochemical identification of OCA-B
and its mechanism of action, cognate cDNAs wereSummary
cloned using both biochemical (Luo and Roeder, 1995)
and genetic screening (Gstaiger et al., 1995; StrubinOCA-B is a B lymphocyte–specific transcription co-
et al., 1995) methods. Analyses of recombinant OCA-Bactivator that mediates tissue- and stage-restricted
(p34) function in cell-free systems and in transfectiontranscription of immunoglobulin genes. Earlier genetic
assays confirmed both physical and functional interac-studies revealed that OCA-B is essential for germinal
tions with Oct-1 and Oct-2 (via their POU domains) oncenter formation and production of secondary immu-
Ig promoters (Gstaiger et al., 1995; Luo and Roeder,noglobulin isotypes. Biochemically purified OCA-B
1995; Strubin et al., 1995) and led to the definition of ancontains p35 and p34 isoforms, and a further analysis
N-terminal OCA-B domain that interacts with the Octhas now revealed that p35 is derived from a newly
POU domain (Cepek et al., 1996; Gstaiger et al., 1996;found isoform, p40. More importantly, it has been
Babb et al., 1997; Chaseman et al., 1999) and a C-termi-found that p35 is myristoylated in vivo and that this
nal activation domain that acts synergistically with Octleads to dramatic changes (including localization to
activation domains to recruit additional coactivatorsmembrane compartments) in its properties. These re-
(Luo et al., 1998).sults suggest that the p35 isoform of OCA-B has func-
The physiological roles of OCA-B were further investi-tions distinct from those of the nuclear p34 and that
gated by genetic disruption of OCA-B expression in miceit might be a component of a signaling pathway that
(Kim et al., 1996; Nielson et al., 1996; Schubart et al.,is required for late-stage B cell development.
1996). These studies showed that, although not required
for early B cell development, OCA-B functions are es-
Introduction sential both for germinal center formation and for effi-
cient secondary Ig isotype production (including IgGs,
The B cell–restricted function of immunoglobulin (Ig) IgA, and IgE). In accordance with the biochemical func-
promoters is mediated mainly by an octamer element tion of OCA-B in activating Ig promoter transcription, it
(59-ATGCAAAT-39) that is conserved in virtually all Ig has been found that the decrease of secondary antibody
heavy (H) and light (L) chain gene promoters, as well as production in OCA-B-deficient mice is largely due to
in some Ig enhancers (reviewed by Staudt and Lenardo, reduced levels of transcription from normally switched
1990). However, this same element is also a key central IgH chain loci, rather than a reduced capacity for class
element for transcription of differentially regulated switching events per se (Kim et al., 1996; Schubart et al.,
genes that include ubiquitously expressed small nuclear 1996). Recent results further demonstrated that OCA-B
RNA genes (snRNA) and cell cycle-regulated histone plays an essential role in efficient transcription from
H2B genes (reviewed in Luo et al., 1992). The regulatory switched IgH loci by directly regulating 39 IgH enhancer
functions of octamer elements, therefore, are likely de- function in conjunction with Oct-1 or Oct-2 (Tang and
pendent on transcription factors that bind this DNA se- Sharp, 1999; Stevens et al., 2000b). On the other hand,
quence. The well-characterized octamer binding tran- the lack of germinal center formation in OCA-B-deficient
scription factors include the ubiquitous Oct-1 and the mice cannot be explained by reduced Ig isotype produc-
B cell–enriched Oct-2, both of which belong to the POU tion, since these are two independent events in B cell
family and share a conserved DNA binding structure development (Vajdy et al., 1995). Therefore, OCA-B may
called the POU domain (reviewed by Herr et al., 1988; regulate germinal center formation by activating the ex-
Wegner et al., 1993). It was originally thought that Oct-2 pression of other target genes or by mediating signal
would account for the tissue-specific activity of Ig pro- pathways that in turn trigger a specific genetic program.
moters, whereas Oct-1 would facilitate transcription of At least two lines of evidence support this idea: (1) B cells
the ubiquitously expressed genes regulated through oc- lacking OCA-B are defective in the proliferative response
to surface IgM cross-linking (Kim et al., 1996); (2) OCA-Btamer elements (e.g., snRNA and histone H2B genes)
expression, which is very low in early B cells but high(Staudt et al., 1986; Cockerill and Klinken, 1990; Murphy
in activated B cells in vivo, can be dramatically andet al., 1992). However, subsequent biochemical (Pierani
synergistically induced in naive B cells by B cell stimuli
(CD40L, Ig cross-linking, and IL4) that are required for* To whom correspondence should be addressed (e-mail: roeder@
germinal center formation (Qin et al., 1998).rockvax.rockefeller.edu).
Our findings in this report raise the possibility that† Present address: Third Wave Technologies, 502 South Rosa Road,
Madison, Wisconsin 53719. OCA-B may be directly involved in B cell signaling path-
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ways through novel mechanisms. We report the pres- mice lacking the 4.5 kb OCA-B gene do not express
OCA-B mRNA in their B cells (Kim et al., 1996). Consis-ence of a novel isoform of OCA-B (p40) that results
from utilization of an upstream alternative translation tent with this, no DNA fragments could be amplified
from spleen mRNAs of OCA-B knockout mice usinginitiation codon and that serves as a precursor to the
p35 isoform of OCA-B. Relative to the conventional p34 primers P1 and P2 or P1 and P3, whereas DNA fragments
of the expected size were amplified from spleen mRNAOCA-B isoform, p35 shows distinct protein modification,
subcellular localization, and transcriptional coactivator of wild-type mice (data not shown). This confirms that
the PCR products shown in Figure 1C are specific forproperties. The unique features of p35 suggest a novel
function for this molecule in signal transduction. OCA-B.
The 1074 bp RT-PCR product was then cloned and
sequenced. The nucleotide sequence from this cDNAResults
fragment and the C-terminal deduced amino acid se-
quence were virtually identical to the previously reportedIdentification of a Novel OCA-B Isoform and Cloning
(Pfisterer et al., 1995) murine OCA-B cDNA and codingof Murine OCA-B cDNA
sequences (data not shown). Notably, however, theEarlier studies showed that the most purified OCA-B is
cDNA sequence suggests the possibility of a novelcomposed of two isoforms, designated p34 and p35,
(longer) translation product beginning with leucine (en-and that both isoforms can reconstitute the activity of
coded by “CTG”) (Figure 1D). Since it is known that CTGOCA-B in stimulating transcription from an IgH promoter
can occasionally serve as a translation initiation codonin Hela nuclear extract (Luo and Roeder, 1995). Micro-
in eukaryotic cells (Mehdi et al., 1990; Kevil et al., 1995),sequencing analyses yielded identical partial internal
this led us to propose that the in-frame CTG upstreamsequences for p34 and p35, as well as a partial N-termi-
of the first ATG in the OCA-B cDNA can function as annal sequence for p34. The inability to obtain N-terminal
alternative translation initiation codon. Significantly, thissequence for p35 suggested that the N terminus was
newly identified region of OCA-B contains the sameblocked and led to speculation that p35 might reflect a
amino acid stretch as the peptide sequence obtainedpost- or cotranslational modification of p34. To further
from microsequencing analysis (Figure 1D, underlined).study this issue, the expression of OCA-B in B cells was
analyzed by Western blot analysis with OCA-B-specific
The p35 Isoform of OCA-B Is Derived from Translationpolyclonal antibodies. In addition to p34 and p35, a
Initiation at the Upstream In-Frame CTGnovel circa 40 kDa polypeptide (referred to as p40) was
In order to determine whether the larger OCA-B isoformsdetected in whole cell extracts of the murine A20 B cell
are generated through translation initiation from the up-line and the human Namalwa B cell line (Figure 1A, lanes
stream in-frame CTG, we performed coupled in vitro3 and 4). In contrast, the p40 polypeptide was rarely
transcription and translation assays. The templates useddetected in nuclear extracts from the same B cell lines
in these assays included wild-type full-length OCA-B(Figure 1A, lanes 1 and 2). To determine its identity, p40
cDNA (wt) and OCA-B cDNAs in which either the CTGwas isolated from Namalwa B cells by means of antibody
(DCTG) or the ATG (DATG) codon had been mutated. Theaffinity chromotography, fractionated by electrophore-
wild-type cDNA template produced two polypeptidessis, and visualized by silver staining (Figure 1B). Subse-
(Figure 2, lane 3), the mobilities of which were identicalquent microsequencing of the purified p40 yielded inter-
to those of the endogenous p34 and p35 forms ofnal sequences identical to those derived from p34 and
OCA-B (Figure 2, lanes 1 and 3). No p40 polypeptidep35, except for one 12-residue peptide with the se-
was evident under the conditions used in these assaysquence NH2-GNILSQAMLWQK-COOH. The sequence of
(Figure 2, lane 3). Nonetheless, p40 was evident whenthe C-terminal five amino acid residues of this peptide
shorter reaction times and doubled amounts of cDNAis identical to that of the five N-terminal residues of p34.
templates were used in the assay (Figure 2, lane 6),However, the sequence of the seven N-terminal residues
suggesting that p40 is unstable and quickly processedof this p40 peptide is unique, suggesting that p40 is a
posttranslationally. In contrast, when the CTG mutatednovel isoform of OCA-B with an extended N terminus.
OCA-B cDNA was used as template, only one polypep-A RT PCR strategy was then used to clone a full-
tide corresponding to the p34 isoform of OCA-B waslength murine cDNA encoding the largest form of
generated (Figure 2, lanes 5 and 7), indicating that theOCA-B. For this purpose, mRNAs of murine A20 cells
p40 and p35 isoforms both derive from translation initia-were amplified using primer pairs corresponding to the
tion at the CTG. On the other hand, mutation at ATG39-end of p34 coding sequence (P1, Figure 1C, left panel)
abolished the production of p34 but not p35 (Figure 2,and indicated sequences in the OCA-B promoter region
lane 4) or p40 (data not shown). In conclusion, p40, p35,(P2, P3, and P4, Figure 1C, left panel), and the amplified
and p34 isoforms of OCA-B are all encoded by the samecDNA fragments were resolved on an agarose gel (Fig-
mRNA, and p35 and p34 represent ultimate translationalure 1C, right panel). As shown in Figure 1C, a single
products from alternative start codons. The p40 poly-DNA fragment of z1.1 kb was generated using primers
peptide, however, is the precursor to p35 and is quicklyP1 and P2 (lane 2). A longer fragment of about 1.3 kb
processed after translation.was generated using primers P1 and P3 (lane 3). The
lengths of each of these two fragments match the
summed lengths (1074 and 1300 bp, respectively) of the The p34 and p35 Isoforms of OCA-B Differ in Their
Abilities to Stimulate Transcription In Vivocorresponding promoter and cDNA regions of OCA-B
gene. No DNA was amplified using primers P1 and P4 Our previous in vitro transcription studies showed that
p34 and p35 could independently stimulate the IgH pro-(lane 4). An earlier Northern blot analysis indicated that
Distinct Functions of OCA-B Isoforms
159
Figure 1. Identification of a Novel Isoform of OCA-B
(A) Western blot analysis of OCA-B expression in B lymphocytes. Nuclear extracts (NE) and whole cell extracts (WCE) were prepared from
Namalwa and A20 B lymphocytes. Equal aliquots of lysates were fractionated by SDS-PAGE, and the endogenous OCA-B polypeptides were
detected by Western blot analysis using two OCA-B-specific antibodies. Two specific bands (corresponding to p35 and p34 isoforms of OCA-B)
were detected from nuclear extracts of these B cells (lanes 1 and 2). In addition to bands of p35 and p34, p40 was also detected in whole
cell extracts from the same B cell lines (lanes 3 and 4). The arrows indicate each of the three isoforms of OCA-B.
(B) Affinity purification of p40. OCA-B was immunopurified from lysates of Namalwa B cells, fractionated by a 12% SDS-PAGE, and visualized by
silver-staining. The p40 isoform of OCA-B was then subjected to microsequencing analysis, and one of the resulting peptide sequences is indicated
in (D). The upper arrow indicates the p40 isoform of OCA-B, and the lower arrow indicates p34 and p35 that are not separable on this gel.
(C) Cloning of OCA-B cDNA from A20 cells. Positions of those primers used for RT-PCR analysis are indicated in the left panel. The PCR products
were fractionated on a 1.5% agarose gel (right panel). Lane 1 shows the molecular markers of DNA. Lanes 2 and 3 show the PCR products amplified
with primers P1 and P2 (with a length of 1074 bp) and primers P1 and P3 (with a length of 1300 bp), respectively. No PCR product was observed
with primers P1 and P4 (lane 4). The arrows indicate the observed PCR products.
(D) N-terminal sequence of p40. Two translational start codons (CTG and ATG, respectively) are shown in bold face. A conservative myristoylation
motif is boxed. The peptide sequence identified by microsequencing analysis is underlined. The arrows indicate the beginning of each isoform of
OCA-B.
moter to a comparable level (Luo and Roeder, 1995). To biochemical studies, p34 stimulated transcription from
the reporter gene with a wild-type octamer element butdetermine their transcriptional coactivation properties
in vivo, we generated vectors that selectively express not from the reporter gene containing a mutated oc-
tamer element (Figure 3A). In contrast, however, thep34 or p35 in mammalian cells as a result of mutation
in either of the two translation initiation codons. Each p35-selective expression vector was unable to activate
reporter gene transcription efficiently (Figure 3A).of these expression plasmids was then transfected into
murine NIH3T3 fibroblast cells (lacking endogenous To confirm this observation, a reporter plasmid con-
taining a genuine IgH promoter was used in the sameOCA-B), together with synthetic luciferase reporter
genes containing a single copy of either a wild-type or assay. As seen in Figure 3B, luciferase activity was mark-
edly increased when p34 was expressed in transfecteda mutated Ig octamer sequence linked to the minimal
promoter. The ability of each isoform to activate tran- cells, especially at higher levels of the vector. However,
consistant with the synthetic reporter results, p35 acti-scription was then evaluated by measuring the lucifer-
ase activities in cell lysates. In agreement with our earlier vated the IgH promoter to a significantly lower level than
Immunity
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COS-7 (Figure 3C; data not shown). Thus, p34 and p35
OCA-B isoforms, at comparable levels of expression,
exhibit different abilities to activate transcription from
octamer element-containing promoters in vivo. How-
ever, and in light of studies showing similar activities
of p34 and p35 in cell free transcription assays (Luo and
Roeder, 1995), this may in part relate to different in-
Figure 2. Expression of Selective OCA-B Isoforms In Vitro tranuclear concentrations of these two isoforms of
The wild-type cDNA (lanes 3 and 6) and OCA-B cDNAs with mutation OCA-B.
at either the first ATG (denoted as “DATG,” lane 4) or the upstream
CTG (denoted as “DCTG,” lanes 5 and 7) were used as templates
for coupled in vitro transcription and translation in the presence of
Distinct Subcellular Localizations of p34 and p35[35S]-methionine. Lane 2 shows a no DNA template control reaction.
in Transfected CellsOne microgram amounts of DNA templates were used for the reac-
tions shown in lanes 2–5. Equivalent aliquots of synthesized prod- To investigate mechanisms underlying the functional
ucts were then fractionated by SDS-PAGE, and radiolabeled p40, differences between p34 and p35, we studied the sub-
p35, and p34 polypeptides were detected by autoradiography. An cellular localizations of these polypeptides in cells. For
aliquot of Namalwa cell lysate was also fractionated on the same
this purpose, COS-7 cells were transfected with plas-SDS-PAGE gel. The endogenous p34 and p35 polypeptides were
mids selectively expressing either p34 or p35, and thedetected by Western blot analysis with OCA-B-specific antibodies
localizations of these polypeptides were investigated by(lane 1). In another experiment, doubled amounts of the indicated
DNA templates (2 mg) and shorter reaction times (20 min) were used immunoflurescence microscopy following cell labeling
for coupled in vitro transcription and translation reactions (shown with OCA-B-specific antibodies and nuclear labeling
in lanes 6 and 7). All of the synthesized products were then fraction- with propidium iodine. In each case, z80% of the cells
ated by SDS-PAGE, and the presence of radiolabeled p40, p35, and
stained positively for OCA-B. As shown in Figure 4, andp34 polypeptides was detected by autoradiography. The arrows
as expected, the p34 isoform of OCA-B was alwaysindicate p40, p35, and p34 polypeptides.
found to be concentrated in the nucleus of transfected
COS-7 cells (panels D–F). Strikingly, in p35-transfected
cells, OCA-B staining always appeared to be mainlydid p34, although comparable levels of p34 and p35
were detected in transfected cells by Western blot anal- cytoplasmic (panels A–C) . Moreover, in some (z3-5%)
p35-transfected cells, membrane signals could also beysis (data not shown). Similar results were also obtained
using murine A20 B lymphocytes (although the presence seen (shown in panel A). Similar distribution patterns of
p34 versus p35 in the subcellular compartments wereof endogenous OCA-B makes these assays less sensi-
tive), as well as cell lines that included 293T, Hela, and also observed when 293T, Hela, T47D, and NIH3T3 cells
Figure 3. Distinct Activities of p34 and p35
in Stimulating Gene Transcription In Vivo
(A) Each culture of NIH3T3 cells was trans-
fected with expression vectors encoding p34
or p35, together with the pRL-SV40 control
plasmid and synthetic luciferase reporter
genes containing either the wild-type (wt,
black bars) or mutated (mutant, gray bars)
octamer sequence linked to a basal pro-
moter. The parental expression plasmid (de-
noted as – under bars) was also transfected
into cells as a negative control. Reporter gene
transcription was determined by measuring
the luciferase activity in each transfected cul-
ture 2 days after transfection. The histograms
represent means from three independent ex-
periments. Error bars represent standard de-
viation from means.
(B and C) Each culture of NIH3T3 cells (B) and
A20 cells (C) was transfected with increasing
amounts of expression vectors (0.5 and 1.5
mg, respectively) selectively expressing p34
and p35 isoforms of OCA-B (indicated under
bars), together with a luciferase reporter gene
containing the IgH promoter and the pRL-
SV40 control plasmid. A parental empty vec-
tor (denoted as – under bars) was also cotrans-
fected into cells as a control. Reporter gene
transcription was determined by measuring
the luciferase activity in each transfected cul-
ture 2 days after transfection. The histograms
represent means from three independent ex-
periments. Error bars represent standard de-
viation from means.
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Figure 4. Distinct Subcellular Localizations of the p34 and p35 Isoforms of OCA-B in COS-7 Cells
Expression vectors selectively encoding p35 (A–C) or p34 (D–F) isoforms of OCA-B were transfected into COS-7 cells. Some COS-7 cells
were transfected with the empty expression vector as a negative control (G–I). After 40 hr, cells were fixed and incubated first with OCA-B-
specific antibodies, then with FITC-conjugated anti-rabbit antibodies (A, D, and G). Nuclei of cells were stained with propidium iodine (PI, [B],
[E], and [H]). The labeled fluorescence was examined by confocol microscopy. Panels c, f, and i show the combined images of (A) and (B),
(D) and (E), and (G) and (H), respectively. Magnification in all of these panels is 403.
were transfected with each of these expression vectors containing the N-terminal residues of p35 was found
largely in the cytoplasm (panels A and B). In contrast, the(data not shown). Therefore, p34 and p35 isoforms of
OCA-B are localized to distinct subcellular compart- GFP fusion protein containing the N-terminal residues of
p34 was located predominantly in the nucleus (panels Cments in transfected cells.
Since the amino acid sequences of p34 and p35 differ and D). These results indicate that the unique N-terminal
sequence of p35 contains a signal that determines itsonly at their N-terminal regions (Figure 1D), we next
tested whether this sequence difference caused the dis- distinct subcellular localization.
tinct subcellular localizations of these two isoforms. For
this purpose, we generated vectors that fused the Myristoylation of p35 Is Responsible for Its
Distinct PropertiesN-terminal region of either p34 or p35 to the N terminus
of GFP (Figure 5). Each of these fusion proteins was The N-terminal seven amino acids that are unique to
p35 constitute a conserved myristoylation motif (Figurethen expressed in COS-7 cells, and their subcellular
localizations were observed by fluorescence micros- 1D). Since protein myristoylation has been found to be
critical in determining the subcellular localization andcopy. As shown in Figure 5, the GFP fusion protein
Immunity
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Figure 5. Difference of Their N-Terminal Sequences Accounts for the Distinct Subcellular Localizations of p35 and p34
The N-terminal 43 amino acid residues of p35 (A) and the N-terminal 36 amino acid residues of p34 (C) were fused to GFP and the expression
vectors encoding each of these fusion protein (shown beside the corresponding images, with the filled gray box representing the myristoylation
motif in p35) were transfected into COS-7 cells. The localization of each GFP-fusion protein was monitored by fluorescence microscopy. (B)
and (D) show the light fields of corresponding COS-7 cells. The magnification of these images is 403.
function of certain polypeptides, we assessed whether in stimulating IgH reporter gene transcription was as-
sessed by a luciferase assay in NIH 3T3 cells (Figurep35 was myristoylated. For this purpose, expression
vectors encoding GFP alone, p34N-GFP, p35N-GFP, 7B). Significantly, the staining pattern of p35(G!A) was
similar to that of p34 (comparing panel A in Figure 7Aand p35N-GFP with the N-terminal glycine residue mu-
tated to alanine (p35N(G!A)-GFP) were transfected into and panel D in Figure 4), and dramatically different from
that of wild-type p35 (Figure 7A, panels A and C). Fur-COS-7 cells. As a positive control, COS-7 cells were
also transfected with a plasmid encoding v-Src. Each thermore, the ability of p35 to activate IgH reporter gene
transcription was also dramatically increased by theof these transfected cells was then labeled with [3H]-myris-
tic acid, and the presence of radio-labeled polypeptides p35(G!A) mutation (Figure 7B). Thus, the distinct prop-
erties of p35 in comparison with those of p34 are directlywas determined by immunoprecipitation (with OCA-B-
specific and v-Src-specific antibodies) and SDS-PAGE related to the myristoylation of p35 in cells.
analysis. Myristoylated v-Src was observed as expected
(Figure 6A, lane 5). Significantly, myristoylation of wild- Discussion
type p35 was also observed (Figure 6A, lane 2), whereas
no myristoylation of wild-type p34 or mutated p35 was Two forms of OCA-B, p34 and p35, have been identified
in our previous biochemical purification studies (Luoobserved (Figure 6A, lanes 3 and 4).
To further study the myristoylation of p35 in B cells, and Roeder, 1995). Here, we report the isolation of a
novel higher molecular weight form (designated p40) ofA20 cells were labeled with either [35S]-methionine or
[3H]-myristic acid, and the presence of radio-labeled p34 OCA-B and the cloning of a full-length murine cDNA.
Our present results indicate that different isoforms ofand p35 was determined by immunoprecipitation with
OCA-B-specific antibodies. As seen in Figure 6B, radio- OCA-B are generated from alternative translation initia-
tion sites on the same mRNA. Thus, both p40 and p35labeled p34 and p35 can both be detected in immuno-
precipitates from lysates of [35S]-methionine-labeled are derived from translation initiation at the upstream
CTG codon, with p40 serving as a precursor to p35,lymphocytes. However, only the p35 isoform was la-
beled by [3H]-myristic acid in A20 cells. These results whereas p34 is derived from translation initiation at the
ATG codon. Moreover, the seven amino acid extensionindicate that p35 is a myristoylated protein in vivo.
We then investigated the influence of p35 myristoyla- at the N terminus of p35 leads to dramatic changes in
its properties, including a predominantly cytoplasmiction on its subcellular localization and transcriptional
activity. To this end, vectors encoding either wild-type and membrane localization and a reduced ability to stim-
ulate Ig promoter activity in vivo. We further show thatp35 or the p35 mutant (p35(G!A)) were transfected into
COS-7 cells, and the subcellular localization of these these unique properties of p35 are caused by myristoyla-
tion through the N-terminal glycine residue in this poly-molecules was studied by immunofluorescence micros-
copy following staining with OCA-B-specific antibodies peptide.
OCA-B was originally isolated as a transcriptional co-(Figure 7A). In addition, the activity of these polypeptides
Distinct Functions of OCA-B Isoforms
163
Figure 6. p35 Is Myristoylated In Vivo
(A) COS-7 cells were transfected with expres-
sion vectors encoding GFP alone (lane 1),
p35N-GFP (lane 2), p35N(G!A)-GFP (lane 3),
and p34N-GFP (lane 4). The plasmid encod-
ing the v-Src polypeptide was also trans-
fected into COS-7 cells as a positive control
(lane 5). After 48 hr, cells were labeled with
[3H]-myristic acid as described in Experimen-
tal Procedures. Equivalent aliquots of lysate
were immunoprecipitated with OCA-B-spe-
cific antibodies or v-Src-specific antiserum.
The immunoprecipitates were then fraction-
ated by SDS-PAGE, and the presence of ra-
diolabeled polypeptides in each immunopre-
cipitate was detected by antoradiography
(upper panel). The upper arrow indicates the
labeled v-Src polypeptide, and the lower arrow indicates the labeled p35N-GFP fusion protein. Aliquots of lysates from the same transfected
cells were also fractionated by electrophoresis, and the expression of each of the GFP-fusion proteins was determined by Western blot
analysis with OCA-B-specific antibodies (lanes 1–4 in the lower panel). Similarly, the expression of the v-Src polypeptide in transfected cells
was also determined (lane 5 in the lower panel).
(B) A20 cells were labeled with [3H]-myristic acid (lanes 1 and 2) or [35S]-methionine (lanes 3 and 4). Lysates were then subjected to immunoprecip-
itation with OCA-B-specific antibodies (lanes 2 and 4) or the corresponding preimmune antiserum (lanes 1 and 3). The immunoprecipitates
were fractionated by SDS-PAGE, and the presence of radiolabeled OCA-B polypeptides was detected by autoradiography. The arrows indicate
the endogenous p35 and p34 polypeptides.
activator of Oct proteins in regulating Ig promoter activ- Kretzschmar and Massague, 1998), SREBPs (reviewed
by Brown and Goldstein, 1997), JAB1 (Bianchi et al.,ity, and it is the first cofactor whose function has been
clearly shown to be cell-, promoter-, and activator-spe- 2000), and b-catenin (Behrens et al., 1996) have been
shown to couple cytoplasmic signal transduction eventscific (reviewed in Luo and Roeder, 1999). Earlier in vitro
transcription analyses showed that the p34 and p35 with the transcription machinery in the nucleus. These
factors show bipartite or tripartite subcellular localiza-isoforms of OCA-B possessed equal abilities to activate
Ig promoter transcription. However, p34 is more potent tions in cells, and they regulate target gene transcription
by direct translocation from cytosol/membrane com-in stimulating the transcription of the same Ig promoter
in transfected cells (up to 5-fold higher than that of p35). partments into the nucleus in response to extracellular
stimuli. Apart from the present finding that the p35 iso-These studies suggest that this phenomenon results
from different nuclear concentrations of these two poly- form of OCA-B can localize to cell membranes and to
the cytosol, both our earlier biochemical purificationpeptides. However, our results do not rule out the possi-
bility that p34 and p35 differ with respect to their intrinsic (Luo and Roeder, 1995) and more recent subcellular
fractionation studies (data not shown) indicate that p35abilities to stimulate Ig promoters in conjunction with
enhancers, and from natural (chromatin) templates, in can also be purified from B cell nuclear extracts in con-
junction with p34. Altogether, these observations raiseliving cells.
Nevertheless, genetic studies of OCA-B null mice sug- the possibility that p35 might undergo cytoplasmic-
nuclear trafficking in B cells and lead to the hypothesisgest additional roles of OCA-B beyond the B cell–
specific activation of Ig gene transcription. Specifically, that the p35 isoform of OCA-B may function as a compo-
nent of BCR signaling pathways and, upon nuclear entry,OCA-B has been shown to be essential for germinal
center formation and for B cell responses to surface regulate the transcription of downstream genes.
The targeting of many signaling molecules to theIgM cross-linking (Kim et al., 1996; Nielson et al., 1996;
Schubart et al., 1996). Two possibilities that are not plasma membrane is a central event for receptor-depen-
dent signal transduction. Distinct molecular mecha-mutually exclusive might explain these observations: (1)
OCA-B may be required for expression of other down- nisms have been shown to account for membrane binding/
cytoplasmic retention of different transcription regula-stream target genes whose functions are critical for ger-
minal center formation and for B cell maturation. The tors. These include mechanisms involving specific pro-
tein-protein interactions or specific signal peptidesobservations that OCA-B expression is responsive to
signals crucial for the formation of germinal centers and (Behrens et al., 1996; Brown and Goldstein, 1997; Leonard
and O’Shea, 1998; Bianchi et al., 2000). Our presentrestricted to activated B cells located mainly in germinal
centers support the idea that OCA-B may function as a results show that myristoylation of p35 at its N-terminal
glycine residue may be responsible, at least in part,mediator to integrate B cell–activation signals and trig-
ger a genetic program leading to germinal center forma- for its cytoplasmic retention and membrane-anchorage.
However, as reported for other myristoylated proteinstion (Qin et al., 1998); (2) OCA-B itself may serve as a
novel type of signaling molecule, since the p35 isoform (reviewed by Resh, 1999), a second signal may also be
required to fully anchor p35 to cellular membranes. Theof OCA-B is myristoylated in vivo and can locate to cell
membranes (this study). fact that plasma membrane-anchored p35 is observed
in only a small percentage of transfected COS-7 cellsWith respect to these possibilities, several transcrip-
tion factors and coactivators, such as STATs (reviewed may reflect the absence of such second signals in this
cell type. However, other possibilities, such as overex-by Leonard and O’Shea, 1998), SMADs (reviewed by
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Figure 7. N-Terminal Myristoylation of p35 Is
Responsible for Its Distinct Biological Prop-
erties
(A) Expression vectors encoding wild-type
p35 (a) or p35 mutant (denoted as p35 (G!A)
[c]) were transfected into COS-7 cells. Forty
hours posttransfection, cells were fixed, per-
meabilized, and stained with OCA-B-specific
antibodies ([a] and [c]) and DAPI ([b] and [d]).
The localization of OCA-B polypeptides was
visualized by fluorescence microscopy. The
magnification is 403.
(B) Each culture of NIH3T3 cells was trans-
fected with IgH reporter plasmid, pRL-SV40
control plasmid, together with expression
vectors encoding p34, p35 or p35(G!A) as
indicated under bars. The luciferase activity
was measured 2 days later and is presented
as fold-stimulation over basal reporter gene
activity in cells. The histograms represent
means from four independent experiments.
Error bars represent standard deviations from
means. The inner panel shows the expression
of p35, p35(G!A), and p34 in corresponding
transfected COS-7 cells.
pression and incomplete cleavage of p40 in COS-7 cells, don and that it is then quickly processed, by removal
of the seven N-terminal amino acid residues, to generatemay also account for inefficient plasma membrane tar-
geting of p35. a p35 isoform with an N-terminal glycine that is then
subject to myristoylation. Our finding that p35 is N-myri-N-myristoylation is one type of posttranslational modi-
fication known to facilitate the membrane targeting of stoylated also explains the N-terminal blockage encoun-
tered in microsequencing analysis.many signaling proteins. For example, myristoylation of
the transforming protein of Rous sarcoma virus (pp60v- It has long been known that the membrane binding
of myristoylated proteins can be regulated. For instance,Src) is necessary for directing Src to the membrane,
and the non-myristoylated form of Src does not bind to guanine nucleotide binding can regulate exposure of
the myristate moiety in ADP ribosylation factor andmembranes and does not mediate cell transformation
(Kamps et al., 1985). An N-terminal glycine is absolutely therefore control its membrane association (Haun et al.,
1993; Boman and Kahn, 1995; Goldberg, 1998). Also,required for protein myristoylation. Such residues often
result from proteolytic cleavage of precursor proteins PKC can phosphorylate the MARCKS protein in its basic
domain, and this results in the displacement of MARCKS(Resh, 1996; Boutin, 1997; Raju et al., 1997; Wedegaert-
ner, 1998). On the basis of OCA-B cDNA sequences and into the cytosol (Thelen et al., 1991). Hence, if our hy-
pothesis (above) of cytoplasmic-nuclear trafficking ofin vitro transcription/translation studies, it is very likely
that p40 results from translation initiation at a CTG co- p35 in B lymphocytes can be confirmed, a further analy-
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formed African Green Monkey cells, were maintained in RPMI 1640sis of mechanisms regulating p35 anchorage to the
medium supplemented with 10% fetal bovine serum.membrane and translocation into the nucleus in B lym-
Cells were transfected with SuperFect reagent according to thephocytes could help in a further understanding of the
manufacturer’s protocol (Qiagene). For NIH3T3 and COS-7 cells,
functions of OCA-B in B lymphopoiesis. In the meantime, z2–4 3 105 cells and 2.5 mg DNA were used per transfected sample,
it will be important to search more directly for other while for A20 B cells, 5 3 106 cells and 12 mg DNA were used
per transfected sample. A pRL-SV40 plasmid was included in eachOCA-B target genes, whose regulation might actually be
transfection reaction as an internal control to minitor the transfectionlinked to the myristoylated form of p35, and to determine
efficiency. Each transfection was done in duplicate, and data fromwhether selective expression of p35 versus p34 in OCA-B
3–4 independent transfections were collected in each set of experi-knockout mice results in distinct phenotypes that can
ments for purpose of statistical analysis.
be related to specific gene expression pathways.
In Vitro Transcription/Translation
Experimental Procedures The various isoforms of OCA-B were in vitro transcribed/translated
with the TNT reticulocyte lysate kit (Promega) in the presence of
Plasmid Construction [35S]-methionine (Amersham Pharmacia Biotech). For each reaction,
The 1074 bp RT-PCR product (see below) was reamplified using 1 or 2 mg of the indicated expression plasmid was used as template.
59-GTACGAATTCATATGGTGGTTAGTCCCAATT-39 and 59-GTACTG The mixtures were then fractionated by SDS-PAGE electrophoresis,
GATCCTAAAAGCCCTCCACGGAG-39 as primers. The amplified and the polypeptide products were visualized by autoradiography.
DNA fragments were cut with NdeI and BamHI and ligated with
similarly digested 6HisT-PRSET (InVitrogen) fragments to generate In Vivo Labeling and Immunoprecipitation
an expression plasmid containing full-length OCA-B cDNA. Expres- COS-7 cells were transfected with the indicated expression vectors.
sion plasmids with mutations at either of the two translation initiation Twenty four hours later, each COS-7 transfection was divided into
codons were produced using Quick Mutagenesis Kit by following two 10 cm plates and incubated at 378C for another 24 hr. One
the protocol provided by the manufacturer (Stratagen, LaJolla, CA). group of transfected COS-7 cells was starved in DMEM without
The resulting vectors are mutated at CTG start codon (DCTG, with methionine for 1 hr and then metabolically labeled with 100 mCi of
CTG mutated to TTT) or at the ATG start codon (DATG, with ATG [35S]-methionine for 4 hr at 378C. The other group of transfected
mutated to TCG). COS-7 cells was incubated at 378C for 1 hr in DMEM with 1%
To make constructs for ectopic expression of p34 and p35 in dialyzed fetal bovine serum and labeled for 2 hr at 378C with 250
transfected cells, the corresponding cDNA fragments were PCR mCi/ml of [3H]-myristic acid (Amersham Pharmacia Biotech). The
amplified using DCTG or DATG as template, digested with KpnI and same conditions were used for B cell labeling, except that 5 3 106
HindIII, and ligated into KpnI-HindII-cut pcDNA3.1(1) (InVitrogen). cells were used for labeling with [35S]-methionine and 5 3 107 cells
The p35(G!A) mutant was generated by inserting the corresponding were used for labeling with [3H]-myristic acid.
cDNA sequences (with GCC changed into GGC) into pcDNA3.1(1). Cells were then harvested and disrupted in lysis buffer (10 mM
To produce expression vectors encoding GFP-fusion proteins, Hepes [pH 7.6], 250 mM NaCl, 5 mM EDTA, and 1% Triton X-100)
a vector containing full-length GFP cDNA was first generated by supplemented with 0.5 mM dithiothreitol, protease inhibitors (2 mg/
inserting the corresponding cDNA sequence into EcoRI-XhoI- ml leupeptin, 1 mg/ml pepstatin, and 1 mM PMSF) and phosphotase
digested pcDNA3.1(1). The cDNA sequences encoding either the inhibitors (5 mM NaF and 0.1 mM vanadate). Each aliquot of lysate
N-terminal 43 amino acids of p35 (p35N) or the N-terminal 36 amino was then coincubated with OCA-B-specific antiserum, its corre-
acids of p34 (p34N) then were inserted 59 of the GFP cDNA in sponding preimmune serum (Luo and Roeder, 1995), or v-Src-spe-
pcDNA3.1(1) following KpnI and EcoRI digestion. The p35N-GFP cific antibodies (kindly provided by Dr. M. Resh) at 48C for 1 hr. After
mutant was constructed by inserting a sequence encoding the adding 20 ml of protein A-Sepharose beads (50% slurry), the mixture
N-terminal 43 amino acid residues of p35(G!A) 59 of the GFP cDNA was rocked at 48C for another 2 hr. The beads were then washed
in pcDNA3.1(1) through the same strategy. four times in lysis buffer with supplements described above, resus-
A plasmid encoding v-Src was generously provided by Dr. M. pended in 12 ml of 23 sample buffer (0.1 M Tris-HCl [pH 6.8], 4%
Resh (Memorial Sloan-Kettering Cancer Center). Synthetic lucifer- SDS, 0.1% b-mercaptoethanol, and 0.004% bromphenol blue), and
ase reporter genes containing wild-type or mutated octamer se- boiled for 5 min. The supernatants were fractionated by electropho-
quences linked to the basal promoter and the luciferase reporter resis.
containing the natural IgH promoter have been described (Stevens
et al., 2000a).
Western Blot Analysis
Thirty micrograms of whole cell extract or 10 mg of nuclear extract
RT-PCR Assay from A20 or Namalwa B cells was fractionated by electrophoresis.
Total RNA was extracted from murine A20 cells and fibroblast For transfected cells, equivalent aliquots of lysates from each trans-
NIH3T3 cells using Trizol Reagent (Life Technologies). Poly(A)1 fection were fractionated by electrophoresis. The proteins then were
RNAs were isolated via the Poly Attract mRNA Isolation System transferred onto PVDF membranes. Western blot analyses were
(Promega). First strand cDNA syntheses were performed using avian performed with both rabbit polyclonal antibodies raised against ei-
myeloblastosis virus (AMV) reverse transcriptase (Promega) with ther the N terminus or the C terminus of recombinant OCA-B (Luo
oligo-(dT) as primer. OCA-B cDNAs were amplified using the follow- and Roeder, 1995). The v-Src-specific antiserum was used to detect
ing primers (see the left panel in Figure 1C): P1: 59-CTAAAAGCC expression of v-Src in transfected COS-7 cells.
CTCCACGGAGAGG-39; P2: 59-ATGGTGGTTAGTCCCAATTGGCT
GGC-39; P3: 59-TGGGACCAATGGTAAGGTCAGTCCTG-39; and P4: Immunofluorescence
59-TTGAAACAGGGACCCCTATATTTTAAAC-39. PCR reactions were Transfected COS-7 cells were grown on 12 mm round glass cov-
performed in a 50 ml mixture containing 0.2 mM dNTPs, 0.2 mM erslips for 24 or 40 hr, fixed with 4% paraformaldehyde in PBS for
primers, and 0.25 Unit of PFU DNA polymerase (Stratagen). After 15 min at room temperature, and permeabilized with 0.2% Triton
30 thermal-cycle amplification, the PCR products were separated X-100 in PBS. After blocking for 1 hr in PBS containing 2% BSA,
by 1.5% agarose gel electrophoresis. the cells were incubated with anti-OCA-B antibodies (diluted to
1/1000) for 2 hr, washed four times, and incubated with anti-immuno-
globulin antibodies coupled to fluorescein (Rockland, Inc.). AfterCell Culture and Transfection Assay
All cell lines used in this paper were obtained from the American staining the nuclei with propidium iodine (PI, Sigma) or DAPI (Vector),
the cells were mounted in 90% glycerol and confocol images wereType Tissue Culture Collection (ATCC). NIH3T3 mouse embryo fibro-
blasts were maintained in DMEM medium supplemented with 10% collected on a Zeiss laser scanning instrument (model LSM 510,
The Rockefeller University Core Facility). The fluorescence of GFPfetal calf serum. Other cell lines, including human Namalwa B lym-
phocytes, murine A20 B lymphocytes, and COS-7 kidney SV40 trans- was viewed directly under a fluorescence microscope.
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Immunopurification Kamps, M.P., Buss, J.E., and Sefton, B.M. (1985). Mutation of NH2-
terminal glycine of p60src prevents both myristoylation and morpho-OCA-B-specific antibodies were coupled to CNBr-activated aga-
rose (Amersham Pharmacia Biotech) to generate OCA-B affinity res- logical transformation. Proc. Natl. Acad. Sci. USA 82, 4625–4628.
ins. The endogenous OCA-B from Namalwa or A20 B cells was then Kevil, C., Carter, P., Hu, B., and DeBenedetti, A. (1995). Translational
purified by affinity chromatography as described (Luo and Roeder, enhancement of FGF-2 by eIF-4 factors, and alternative utilization
1995). of CUG and ACG codons for translation initiation. Oncogene 11,
2339–2348.
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